Table 3 Baseline information
Feature | n | (%) |
|---|---|---|
Independent Variable | ||
Blood Concentration of TAC, n, Class 1 | 1292 | 70.64 |
Class 0 | 537 | 29.36 |
Demographic Information | ||
Age, yr, median (IQR) | 53 (39, 64) | – |
Weight, kg, median (IQR) | 72 (64, 80) | – |
Height, cm, median (IQR) | 170 (162, 174) | – |
FK506, mg, median (IQR) | 1.5 (1, 2) | – |
Sex, Male | 1241 | 67.85 |
Female | 588 | 32.15 |
Laboratory Information | ||
SC, μmol/L, median (IQR) | 80.9 (65.8, 103.1) | – |
Combined Medication | ||
CαK, n, Class 1 | 158 | 8.64 |
Class 0 | 1671 | 91.36 |
SYKF, n, Class 1 | 110 | 6.01 |
Class 0 | 1719 | 93.99 |
SYS, n, Class 1 | 225 | 12.30 |
Class 0 | 1604 | 87.70 |
SSN, n, Class 1 | 119 | 6.51 |
Class 0 | 1710 | 93.49 |
HK, n, Class 1 | 824 | 45.05 |
Class 0 | 1005 | 54.95 |
BL, n, Class 1 | 724 | 39.58 |
Class 0 | 1105 | 60.42 |
Pidotimod, n, Class 1 | 851 | 46.53 |
Class 0 | 978 | 53.47 |
MPS, n, Class 1 | 537 | 29.36 |
Class 0 | 1292 | 70.64 |
PA, n, Class 1 | 294 | 16.07 |
Class 0 | 1535 | 83.93 |
MM, n, Class 1 | 19 | 1.04 |
Class 0 | 1810 | 98.96 |
TG, n, Class 1 | 43 | 2.35 |
Class 0 | 1786 | 97.65 |